b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30818110</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>08</Month>\n            <Day>02</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>10</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1532-2238</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>45</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>04</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Growth hormone &amp; IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society</Title>\n                <ISOAbbreviation>Growth Horm. IGF Res.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone?</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>20-24</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1096-6374(19)30011-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ghir.2019.02.002</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">GH excess in acromegaly leads to lower fat mass and insulin resistance; both reverse following pituitary surgery. Soluble delta like-1 homolog (sDlk1) inhibits adipocyte differentiation and may mediate the antiadipogenic effects of GH. It is released into the circulation by ectodomain shedding through \'A Disintegrin And Metalloproteinase domain 17\' (ADAM17), which also sheds soluble \xce\xb1-Klotho (sKlotho). Klotho is a transmembrane protein, which influences life span. sKlotho inhibits insulin signalling, and is markedly elevated in acromegaly and decreases after surgery. Therefore, we examined if sDlk1 parallels the course of sKlotho, which could explain the well-known changes in fat mass in patients with acromegaly after surgery.</AbstractText>\n                <AbstractText Label="DESIGN">We measured serum levels of GH, IGF-1, sDlk1 and sKlotho (both by ELISA) in 42 treatment-na\xc3\xafve acromegaly patients (20 females/22 males) before and 1-3\xe2\x80\xafmonths after transsphenoidal surgery. Data are presented as median(interquartile range).</AbstractText>\n                <AbstractText Label="RESULTS">GH decreased in all patients postoperatively (in 32/42 to &lt;1\xe2\x80\xafng/ml during oral glucose tolerance testing). Likewise, IGF-1 and sKlotho decreased in all patients, from 587 (432-708) to 195 (133-270)\xe2\x80\xafng/ml, and from 4.0 (2.7-5.9) to 0.7 (0.6-1.2)\xe2\x80\xafng/ml, respectively; sDlk1 fell in 40/42 subjects, from 10.7 (5.8-13.4) to 7.1 (3.7-10.4)\xe2\x80\xafng/ml following pituitary surgery. P\xe2\x80\xaf&lt;\xe2\x80\xaf0.0001 for all parameters.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">sDlk1 declined after pituitary surgery in our patients with acromegaly, but to a lesser extent than sKlotho. It remains to be seen whether this may contribute to the well-known postoperative changes in body composition. Our findings may extend beyond the scope of acromegaly, and thus further elucidate mechanisms in the fields of obesity and anti-ageing.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sze</LastName>\n                    <ForeName>Lisa</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Endocrinology and Diabetology, Kantonsspital Winterthur, Brauerstrasse 15, CH-8401 Winterthur, Switzerland; Division of Endocrinology and Diabetology, University Hospital Zurich, R\xc3\xa4mistrasse 100, CH-8091 Zurich, Switzerland. Electronic address: lisa.sze@ksw.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tschopp</LastName>\n                    <ForeName>Oliver</ForeName>\n                    <Initials>O</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Endocrinology and Diabetology, University Hospital Zurich, R\xc3\xa4mistrasse 100, CH-8091 Zurich, Switzerland. Electronic address: oliver.tschopp@usz.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Neidert</LastName>\n                    <ForeName>Marian C</ForeName>\n                    <Initials>MC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, University Hospital Zurich, Frauenklinikstrasse 10, CH-8091 Zurich, Switzerland. Electronic address: marian.neidert@usz.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bernays</LastName>\n                    <ForeName>Ren\xc3\xa9 L</ForeName>\n                    <Initials>RL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, University Hospital Zurich, Frauenklinikstrasse 10, CH-8091 Zurich, Switzerland; Department of Neurosurgery, Klinik Hirslanden, Witellikerstrasse 40, CH-8032 Zurich, Switzerland. Electronic address: rene.bernays@hirslanden.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ghirlanda</LastName>\n                    <ForeName>Claudia</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Endocrinology and Diabetology, University Hospital Zurich, R\xc3\xa4mistrasse 100, CH-8091 Zurich, Switzerland. Electronic address: claudia.ghirlanda@usz.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zwimpfer</LastName>\n                    <ForeName>Cornelia</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Endocrinology and Diabetology, University Hospital Zurich, R\xc3\xa4mistrasse 100, CH-8091 Zurich, Switzerland. Electronic address: cornelia.zwimpfer@usz.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wiesli</LastName>\n                    <ForeName>Peter</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Endocrinology and Diabetology, Kantonsspital Frauenfeld, Pfaffenholzstrasse 4, CH-8501 Frauenfeld, Switzerland. Electronic address: peter.wiesli@stgag.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schmid</LastName>\n                    <ForeName>Christoph</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Endocrinology and Diabetology, University Hospital Zurich, R\xc3\xa4mistrasse 100, CH-8091 Zurich, Switzerland. Electronic address: christoph.schmid@usz.ch.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>18</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Scotland</Country>\n            <MedlineTA>Growth Horm IGF Res</MedlineTA>\n            <NlmUniqueID>9814320</NlmUniqueID>\n            <ISSNLinking>1096-6374</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C512941">DLK1 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D036341">Intercellular Signaling Peptides and Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>12629-01-5</RegistryNumber>\n                <NameOfSubstance UI="D019382">Human Growth Hormone</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.4.24.86</RegistryNumber>\n                <NameOfSubstance UI="D000072198">ADAM17 Protein</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.4.24.86</RegistryNumber>\n                <NameOfSubstance UI="C000606462">ADAM17 protein, human</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="ErratumIn">\n                <RefSource>Growth Horm IGF Res. 2020 Apr;51:77</RefSource>\n                <PMID Version="1">31466842</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000072198" MajorTopicYN="N">ADAM17 Protein</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000172" MajorTopicYN="N">Acromegaly</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D050156" MajorTopicYN="N">Adipogenesis</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002135" MajorTopicYN="N">Calcium-Binding Proteins</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019382" MajorTopicYN="N">Human Growth Hormone</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D036341" MajorTopicYN="N">Intercellular Signaling Peptides and Proteins</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010902" MajorTopicYN="N">Pituitary Gland</DescriptorName>\n                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Acromegaly</Keyword>\n            <Keyword MajorTopicYN="Y">Delta-like homolog 1</Keyword>\n            <Keyword MajorTopicYN="Y">Growth hormone</Keyword>\n            <Keyword MajorTopicYN="Y">IGF-1</Keyword>\n            <Keyword MajorTopicYN="Y">Klotho</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>07</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>23</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30818110</ArticleId>\n            <ArticleId IdType="pii">S1096-6374(19)30011-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ghir.2019.02.002</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'